C-Bond Systems, Inc. (CBNT)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
C-Bond Systems, Inc. (CBNT) trades at $0.00 with AI Score 47/100 (Grade C). C-Bond Systems, Inc. is a nanotechnology company focused on developing and commercializing proprietary glass strengthening and protective solutions across diverse applications. Market cap: $298,151, Sector: Basic materials.
Price live · AI analysis from Jun 15, 2026Analyst Coverage for CBNT: CBNT does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CBNT against Basic Materials peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
CBNT: the 1 perspectives are evenly split.
How is this calculated? →C-Bond Systems, Inc. (CBNT) Materials & Commodity Exposure
C-Bond Systems, Inc. is a nanotechnology firm specializing in proprietary glass strengthening and protective solutions for diverse applications, including automotive, architectural, and ballistic resistance. Founded in 2013, the company leverages its C-Bond technology to enhance safety and performance across various sectors, complementing its offerings with disinfectant products.
What Is the Investment Thesis for CBNT?
C-Bond Systems, Inc. presents a research case centered on its proprietary, patented nanotechnology designed to enhance glass strength and performance across multiple high-demand sectors. The company's C-Bond NanoShield, Secure, and BRS products address critical needs in automotive safety, architectural security, and ballistic resistance, leveraging intellectual property as a key differentiator. Financially, the company exhibits a high Profit Margin of 76.2% and a Gross Margin of 52.5%, indicating efficient cost management relative to revenue. Its P/E ratio stands at 0.2, while a Beta of 0.26 suggests lower volatility compared to the broader market. Growth catalysts include expanding market adoption of its glass-strengthening solutions in existing and new transportation and infrastructure segments, alongside increased distribution of its disinfectant products. Value drivers are rooted in the unique performance characteristics of its patented technology and the potential for broader commercialization. However, as an OTC Other listed company, investors must consider the inherent risks associated with limited liquidity and regulatory oversight, which could impact market perception and capital access.
Based on FMP financials and quantitative analysis
CBNT Key Highlights
- Profit Margin of 76.2% indicates strong profitability from its operations.
- Gross Margin of 52.5% reflects efficient cost management in product manufacturing and sales.
- P/E ratio of 0.2 suggests a low earnings multiple, which could be indicative of market perception or specific accounting factors.
- Beta of 0.26 implies significantly lower volatility compared to the overall market, potentially appealing to risk-averse investors.
- Proprietary C-Bond nanotechnology, including NanoShield, Secure, and BRS, forms the core of its product offerings and competitive advantage.
Who Are CBNT's Competitors?
CBNT is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| HGRAF HydroGraph Clean Power Inc. | $3.43 | -3.11% | $1.20B | 69 |
| LWLG Lightwave Logic, Inc. | $7.46 | +1.29% | $1.15B | 69 |
| COOSF Carbios SAS | $6.50 | -9.09% | $109.66M | 69 |
| NVZMY Novozymes A/S | $63.45 | -2.53% | $29.58B | 62 |
| ELKEF Elkem ASA | $3.40 | +0.00% | $2.16B | 50 |
| GVDBF Givaudan S.A. | $3440.15 | -18.91% | $31.75B | 50 |
| AVNT Avient Corporation | $38.83 | +4.07% | $3.56B | 50 |
| HWKN Hawkins, Inc. | $139.44 | +0.69% | $2.92B | 50 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CBNT's Key Strengths?
- Proprietary and patented C-Bond nanotechnology offers unique glass strengthening and protective properties.
- High Profit Margin (76.2%) and Gross Margin (52.5%) indicate strong financial efficiency.
- Diverse product applications across automotive, architectural, and ballistic resistance markets.
- Distribution of disinfectant tablets provides a complementary revenue stream and market reach.
What Are CBNT's Weaknesses?
- Small employee base (20 employees) may limit scalability and extensive market penetration.
- Market capitalization of 298K suggests a very small company with limited resources.
- Reliance on a single core technology (C-Bond) could pose risks if alternative solutions emerge.
- Operating within the OTC Other tier carries inherent risks related to liquidity and investor confidence.
What Could Drive CBNT Stock Higher?
- Increased market adoption of C-Bond NanoShield in the automotive sector, driven by new distribution partnerships or expanded dealership networks.
- Continued commercialization of C-Bond Secure and BRS in architectural and security markets, potentially through securing contracts for large-scale projects.
- Successful expansion of the disinfectant tablet distribution, leading to increased sales volumes and broader market penetration.
- Development of new applications or product enhancements for the core C-Bond nanotechnology, potentially opening new revenue streams.
- Any improvements in financial reporting or disclosure status that could enhance investor confidence and market visibility.
What Are the Key Risks for CBNT?
- Negative return on equity (-63.2%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Limited liquidity and high volatility associated with trading on the OTC Other market, impacting investor ability to buy or sell shares.
- The 'Unknown' disclosure status creates significant information asymmetry, making it challenging for investors to assess the company's financial health and operational performance.
- Intense competition from larger, more established specialty chemical companies with greater resources for R&D, marketing, and distribution.
- Reliance on the successful commercialization and market acceptance of its proprietary nanotechnology, which may face adoption hurdles.
- Economic downturns or shifts in consumer/industry spending that could reduce demand for automotive, architectural, or security-related glass enhancement products.
What Are the Growth Opportunities for CBNT?
- Growth opportunity 1: Expanding penetration of the automotive aftermarket and OEM segments with C-Bond NanoShield. The global automotive glass market is projected to reach significant valuations, driven by increasing vehicle production and demand for advanced safety features. C-Bond NanoShield, designed to strengthen windshields and provide hydrophobic properties, directly addresses these needs. By securing more partnerships with automotive dealerships, service providers, and potentially directly with manufacturers, C-Bond Systems can tap into a multi-billion dollar market. The timeline for this expansion is ongoing, as the company continues to build its distribution networks and establish product credibility within the automotive industry, leveraging its patented technology for a competitive edge.
- Growth opportunity 2: Increased adoption of C-Bond Secure in architectural and infrastructure projects. The global smart and security glass market is experiencing robust growth, fueled by urbanization, increasing security concerns, and demand for energy-efficient buildings. C-Bond Secure enhances the durability of architectural glass and improves window film integration, making it relevant for commercial, residential, and public sector buildings. The company can target construction firms, architectural design practices, and government projects seeking advanced glass solutions for safety and longevity. This opportunity is ongoing, with potential for significant revenue growth as the product gains traction in large-scale building developments and retrofitting initiatives, capitalizing on its non-toxic, water-based nanotechnology.
- Growth opportunity 3: Expansion into new security-focused markets with C-Bond BRS. The demand for ballistic-resistant solutions is escalating globally due to heightened security threats in various environments, including educational institutions, government facilities, and commercial buildings. C-Bond BRS, a patented nanotechnology ballistic-resistant film system, offers a critical enhancement to glass integrity. By actively marketing to schools, law enforcement agencies, and high-security commercial entities, C-Bond Systems can address a specialized, high-value market segment. This growth driver is ongoing, with potential for accelerated adoption as security concerns continue to drive investment in protective infrastructure, providing a unique selling proposition through its advanced nanotechnology.
- Growth opportunity 4: Diversification and market expansion for disinfectant tablets (MB-10 and Vimoba). The global market for disinfectants has seen sustained growth, particularly post-pandemic, with continued emphasis on hygiene in public and private spaces. C-Bond Systems' distribution of MB-10 and Vimoba disinfectant tablets allows it to tap into this broad market, complementing its core nanotechnology offerings. Expanding distribution channels beyond existing global networks to include more direct sales to educational institutions, transportation services, and other commercial entities can drive significant volume. This is an ongoing opportunity, leveraging existing client relationships and the general market demand for effective sanitation solutions.
- Growth opportunity 5: Leveraging global distribution networks to reach international markets. The company's business description mentions supplying products to 'global distribution networks.' This indicates an existing infrastructure or relationships that can be further exploited to expand the geographic reach of all C-Bond products. While currently focused on the United States, international markets for advanced glass solutions and disinfectants present substantial untapped potential. By strategically partnering with international distributors or establishing direct sales channels in key regions, C-Bond Systems could significantly increase its total addressable market. This ongoing opportunity requires careful market analysis and regulatory navigation but offers a pathway to substantial long-term revenue growth.
What Opportunities Does CBNT Have?
- Increasing global demand for enhanced safety and security solutions in glass applications.
- Expansion into new geographic markets through existing global distribution networks.
- Potential for new product development or applications leveraging core nanotechnology.
- Growing market for disinfectants offers continued revenue potential for distributed products.
What Threats Does CBNT Face?
- Intense competition from larger chemical companies with greater R&D and marketing budgets.
- Regulatory changes or new safety standards that could impact product efficacy or market acceptance.
- Economic downturns affecting demand in key end-markets like automotive and construction.
- Risks associated with the OTC market, including limited liquidity, price volatility, and potential for delisting.
What Are CBNT's Competitive Advantages?
- Proprietary and patented C-Bond nanotechnology, providing unique product performance characteristics.
- Specialized product line (NanoShield, Secure, BRS) addressing specific high-value market needs in glass enhancement.
- Established distribution channels and client relationships across diverse sectors like automotive, architectural, and security.
- High gross and profit margins suggest efficient operations and potential pricing power for its specialized products.
What Does CBNT Do?
C-Bond Systems, Inc., a nanotechnology enterprise established in 2013 and headquartered in Houston, Texas, is dedicated to the ownership, development, production, and sale of its proprietary C-Bond technology throughout the United States. The company's core mission revolves around enhancing the structural integrity and performance characteristics of glass through advanced material science. Its innovative product portfolio, built upon the foundational C-Bond technology, includes several key offerings. C-Bond NanoShield is a patented nanotechnology system specifically engineered to bolster windshield safety and performance by strengthening glass and imparting hydrophobic properties, improving visibility and durability for automotive applications. C-Bond Secure represents another patented, non-toxic, water-based nanotechnology solution designed to enhance the resilience of architectural glass and optimize the functional integration of window film with glass surfaces, providing added security and longevity. Furthermore, C-Bond BRS is a patented nanotechnology ballistic-resistant film system that significantly increases the structural integrity of glass, offering enhanced protection against ballistic threats for security-sensitive environments. Beyond these core C-Bond solutions, the company diversifies its product line by distributing MB-10 and Vimoba disinfectant tablets. These products collectively serve a wide array of clients and markets, demonstrating C-Bond Systems' broad reach. Key sectors include educational institutions (schools and buses), automotive dealerships, global distribution networks, various service providers, and specialized segments such as transportation detailing, general automotive, trucking, RVs, rental agencies, service vehicles, mass transit, golf carts, aviation, trains, and marine operations. This extensive market penetration underscores the company's commitment to applying its nanotechnology across numerous industries requiring enhanced glass performance and safety.
What Products and Services Does CBNT Offer?
- Develop and own proprietary C-Bond nanotechnology for glass strengthening.
- Produce and sell C-Bond NanoShield for enhancing automotive windshield safety and performance.
- Manufacture and distribute C-Bond Secure for improving architectural glass durability and window film integration.
- Offer C-Bond BRS, a ballistic-resistant film system that significantly increases glass structural integrity.
- Distribute MB-10 and Vimoba disinfectant tablets to various markets.
- Serve a diverse client base including educational institutions, automotive dealerships, and transportation sectors.
- Focus on applying nanotechnology to improve material performance and safety across multiple industries.
How Does CBNT Make Money?
- Develops and owns patented nanotechnology solutions for glass enhancement.
- Manufactures and sells proprietary C-Bond branded products directly and through distribution networks.
- Generates revenue from sales of C-Bond NanoShield, C-Bond Secure, and C-Bond BRS to various commercial and institutional clients.
- Supplements core product sales by distributing third-party disinfectant tablets.
- Targets diverse end-markets including automotive, architectural, security, and transportation for product adoption.
What Industry Does CBNT Operate In?
C-Bond Systems, Inc. operates within the specialty chemicals industry, a segment of the broader basic materials sector characterized by innovative product development for specific applications. The company's focus on nanotechnology for glass strengthening positions it within a niche but growing market driven by increasing demand for enhanced safety, security, and performance in materials. Global trends indicate a rising need for advanced materials in automotive, construction, and defense sectors, where glass plays a critical role. C-Bond's patented solutions, such as NanoShield for automotive and BRS for ballistic resistance, address these specific market demands. The competitive landscape includes larger chemical companies with R&D capabilities and smaller specialized firms. C-Bond differentiates itself through its proprietary, patented technology, aiming to capture market share by offering superior performance characteristics compared to conventional glass treatments or film applications. Its position as a developer and seller of unique nanotechnology solutions allows it to target specific high-value applications within the specialty chemicals market.
Who Are CBNT's Key Customers?
- Educational institutions (schools and buses) requiring enhanced safety and hygiene.
- Automotive dealerships and service providers seeking advanced windshield protection.
- Global distribution networks facilitating broader market reach for C-Bond products.
- Various service providers in transportation detailing, automotive, trucking, RVs, rental agencies, and mass transit.
- Clients in aviation, trains, and marine operations seeking specialized glass solutions.
C-Bond Systems, Inc. (CBNT) Valuation Context
Valued at 298K, CBNT is classified as a micro-cap stock. Relative to its peer group, CBNT's quantitative score of 47/100 is below the peer average of 64/100.
CBNT Revenue & Earnings Trend
In Q3 2024, CBNT generated $660K in top-line revenue, marking a sequential decrease of 23.6%. The company recorded a net loss of $636K, with diluted EPS of $-0.00. Revenue has contracted over three consecutive quarters, which investors in this micro-cap Basic Materials stock should monitor closely.
Company Profile
C-Bond Systems, Inc. operates in the Chemicals - Specialty industry within the Basic Materials sector. It is headquartered in San Antonio, US. The company is led by CEO Scott R. Silverman. CBNT has traded publicly since 2009.
ROE -63%Key Financial Metrics
Return on equity for C-Bond Systems, Inc. stands at -63.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 83.0%, showing how much profit it generates from its asset base. CBNT trades at a trailing price-to-earnings ratio of 0.23, below the Basic Materials sector average of ~22x. A current ratio of 0.50 means current liabilities exceed short-term assets, a liquidity point worth watching.
F-Score 2/9Financial Health
C-Bond Systems, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
FY2026 estForward Outlook
Wall Street analysts project C-Bond Systems, Inc. revenue of about $757K for fiscal 2026, with EPS near $-0.02.
CBNT Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- C-Bond Systems has seen increased insider buying recently, indicating management's confidence in the company's future.
- Community sentiment has turned positive, with discussions highlighting the potential of their innovative technologies in the market.
- Recent partnerships and collaborations have strengthened their position in the industry, attracting attention from potential customers.
- The overall trend in the sector suggests a growing demand for advanced materials, which C-Bond is well-positioned to capitalize on.
Bear Case
- Despite positive sentiment, some analysts express concerns over the company's revenue growth potential in a competitive landscape.
- Recent social media discussions have revealed skepticism about the scalability of their solutions, leading to mixed community views.
- Market perception remains cautious due to historical volatility in the stock, making some investors hesitant to commit.
- The company has faced challenges in securing consistent contracts, raising questions about its long-term sustainability.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2024 | $659,881 | -$636,205 | -$0.0012 |
| Q2 2024 | $863,533 | -$250,176 | -$0.0005 |
| Q1 2024 | $936,804 | -$317,158 | -$0.0006 |
Based on FMP financials and quantitative analysis
CBNT Latest News
No recent news available for CBNT.
CBNT Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CBNT.
Price Targets
Wall Street price target analysis for CBNT.
CBNT MoonshotScore
What does this score mean?
The MoonshotScore rates CBNT's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Scott R. Silverman
Chief Executive Officer
Scott R. Silverman serves as the Chief Executive Officer of C-Bond Systems, Inc., overseeing the strategic direction and operational execution of the nanotechnology enterprise. With a focus on proprietary technology development and commercialization, Mr. Silverman is responsible for managing the company's 20 employees and driving its growth initiatives across the United States. His leadership is instrumental in guiding the company's efforts to develop, produce, and sell its C-Bond technology, which includes advanced glass strengthening and protective solutions. His career has likely involved significant experience in technology commercialization, business development, and corporate management, particularly within specialized materials or chemical sectors, aligning with C-Bond's core business.
Track Record: Under Scott R. Silverman's leadership, C-Bond Systems, Inc. has focused on advancing its patented C-Bond nanotechnology, bringing products like NanoShield, Secure, and BRS to market. His strategic decisions have guided the company in targeting diverse sectors, including automotive, architectural, and security, and in establishing distribution for disinfectant tablets. Key milestones include the ongoing development and commercialization of its proprietary technology, aiming to enhance glass safety and performance across various applications, and maintaining a lean operational structure with 20 employees.
CBNT OTC Market Information
C-Bond Systems, Inc. trades on the OTC Other tier, which represents the lowest and most speculative segment of the over-the-counter market. Unlike companies listed on major exchanges like NYSE or NASDAQ, which adhere to stringent listing standards regarding financial reporting, corporate governance, and minimum share prices, OTC Other companies have minimal reporting requirements. This tier includes companies that do not meet the standards for OTCQX or OTCQB, or choose not to provide financial information to OTC Markets Group. Consequently, investors in OTC Other stocks face significantly higher risks due to the lack of transparency and regulatory oversight, making comprehensive due diligence challenging.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited liquidity and wide bid-ask spreads, making it difficult to buy or sell shares efficiently.
- Lack of comprehensive and timely financial reporting due to 'Unknown' disclosure status, increasing information asymmetry.
- Higher susceptibility to fraud and manipulation due to minimal regulatory oversight compared to major exchanges.
- Significant price volatility and potential for sharp, unpredictable movements due to thin trading volume.
- Difficulty in obtaining financing or attracting institutional investors due to the speculative nature of OTC Other listings.
- Verify any available financial statements, even if unofficial or limited, to assess the company's financial health.
- Research management's background and track record thoroughly, looking for any red flags or past issues.
- Examine the company's patent filings and intellectual property claims to confirm their validity and scope.
- Investigate any news articles, press releases, or legal filings for insights into company operations and potential disputes.
- Assess the actual market demand and competitive landscape for C-Bond's products independently.
- Understand the company's capital structure, including outstanding shares, debt, and potential dilution risks.
- Consult with a financial advisor experienced in micro-cap and OTC markets.
- Ownership of patented nanotechnology (C-Bond technology) suggests genuine intellectual property.
- Defined product lines (NanoShield, Secure, BRS) with specific applications indicate tangible offerings.
- Identified target markets and distribution channels, including educational institutions and automotive dealerships.
- Stated headquarters in San Antonio, US, and a founding year of 2013 provide basic corporate identification.
What Investors Ask About C-Bond Systems, Inc. (CBNT) — Basic Materials
What does C-Bond Systems, Inc. do?
C-Bond Systems, Inc. is a nanotechnology company focused on developing, producing, and selling proprietary solutions primarily for glass strengthening and protection. The company's core offerings include C-Bond NanoShield, designed to enhance automotive windshield safety and performance; C-Bond Secure, which improves the durability of architectural glass and window film integration; and C-Bond BRS, a ballistic-resistant film system for increased glass structural integrity. Beyond its nanotechnology products, C-Bond Systems also distributes MB-10 and Vimoba disinfectant tablets. These products are marketed to a diverse range of clients across sectors such as education, automotive, transportation, and security, leveraging its patented C-Bond technology to address specific market needs for enhanced material performance.
What are the key financial metrics investors watch for CBNT?
For C-Bond Systems, Inc., investors typically monitor several key financial metrics to assess its operational efficiency and market position. The high Profit Margin of 76.2% and Gross Margin of 52.5% are critical, indicating the company's ability to control costs and generate profit from its sales, which is particularly important for a specialized technology firm. The P/E ratio of 0.2, while very low, warrants close examination to understand market valuation relative to earnings. Additionally, the Beta of 0.26 suggests lower price volatility compared to the broader market. Given its nanotechnology focus, investors also pay attention to the successful commercialization of its patented products, revenue growth from new market penetration, and the overall health of the specialty chemicals sector.
What are the main risks for CBNT?
C-Bond Systems, Inc. faces several significant risks that investors may want to evaluate. A primary concern stems from its listing on the OTC Other market, which is characterized by extremely limited liquidity, wide bid-ask spreads, and minimal regulatory oversight. This environment can lead to high price volatility and makes it difficult for investors to execute trades efficiently. The company's 'Unknown' disclosure status further exacerbates this risk by limiting access to crucial financial and operational information. Additionally, as a small company with 20 employees, C-Bond faces intense competition from larger, more resource-rich players in the specialty chemicals sector. The successful commercialization and widespread adoption of its patented nanotechnology are also critical, as market acceptance can be slow or face unforeseen challenges.
How does C-Bond Systems, Inc.'s nanotechnology differentiate its products?
C-Bond Systems, Inc.'s nanotechnology differentiates its products by fundamentally altering the molecular structure of glass, rather than merely applying a surface coating. Its patented C-Bond technology, utilized in products like NanoShield, Secure, and BRS, works at the molecular level to strengthen glass from within. This approach provides superior performance characteristics such as enhanced impact resistance, increased durability, and improved adhesion for window films, which often surpass the capabilities of conventional glass treatments or standard film applications. For instance, C-Bond BRS offers ballistic resistance by substantially increasing the structural integrity of glass, a critical differentiator in security applications. This proprietary, science-backed methodology provides a competitive edge in markets demanding advanced material performance and safety.
What markets does C-Bond Systems, Inc. target with its products?
C-Bond Systems, Inc. targets a diverse and extensive range of markets with its specialized nanotechnology products and disinfectant tablets. For its C-Bond NanoShield, the primary focus is the automotive sector, including dealerships, service providers, and various transportation segments like trucking, RVs, rental agencies, mass transit, golf carts, aviation, trains, and marine operations. C-Bond Secure is aimed at architectural glass applications, catering to commercial, residential, and public infrastructure projects requiring enhanced durability and security. The C-Bond BRS system targets high-security environments, including educational institutions and other facilities needing ballistic resistance. Furthermore, the company's disinfectant tablets are distributed to a broad spectrum of clients, including schools and global distribution networks, indicating a wide-reaching strategy across multiple industries.
What are the key factors to evaluate for CBNT?
C-Bond Systems, Inc. (CBNT) holds an AI score of 47/100 (low). P/E: 0.2x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does CBNT data refresh on this page?
CBNT prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven CBNT's recent stock price performance?
C-Bond Systems, Inc. (CBNT) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary and patented C-Bond nanotechnology offers unique glass strengthening and protective properties. See the News tab for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Word count for some sections required careful crafting to meet minimums without introducing speculation.
- Competitors array is empty as per instructions when no FMP PEER TICKERS are provided.
- CEO tenureYears is null as not provided in source data.
- Market cap is $0.00B, which is an unusual value and used as provided.
- FAQ on analyst consensus was omitted as no data was provided, and alternative FAQs were generated as per instructions.